Put Options Transactions Made in Q4 2023 in Rocket Pharmaceuticals, Inc. (RCKT)
This table provides information about the institutional ownership of Rocket Pharmaceuticals, Inc. (RCKT) during Q4 2023. The information is specifically focused on institutions that hold put options of ROCKET PHARMACEUTICALS, INC..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 15, 2024
Q4 2023
|
Barclays PLC
London, X0 |
BUY
|
PUT |
47.4KNew |
$795K - $1.51M
|
47.4K
$557K
|
|
Feb 14, 2024
Q4 2023
|
Caption Management, LLC
Oklahoma City, OK |
BUY
|
PUT |
30KNew |
$503K - $958K
|
30K
$353K
|
|
Feb 14, 2024
Q4 2023
|
J. Goldman & CO LP
New York, NY |
BUY
|
PUT |
27KNew |
$453K - $862K
|
27K
$318K
|
|
Feb 14, 2024
Q4 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
PUT |
3.9K+ 19.31% |
$65.4K - $125K
|
24.1K
$283K
|
|
Feb 13, 2024
Q4 2023
|
Jefferies Financial Group Inc.
New York, NY |
SELL
|
PUT |
-4.4K- 89.8% |
$73.8K - $141K
|
500
$5.88K
|
|
Feb 14, 2024
Q4 2023
|
Wolverine Trading, LLC
Chicago, IL |
SELL
|
PUT |
-4.7K- 24.74% |
$78.9K - $150K
|
14.3K
$168K
|
|
Feb 14, 2024
Q4 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
PUT |
-11.9K- 43.43% |
$200K - $380K
|
15.5K
$182K
|